Ionis Pharmaceuticals Inc

Health

This little-known pharma stock can rally 50%, Citi says

Newsology1 year ago02 mins

[ad_1] It’s time to buy shares of Ionis Pharmaceuticals , according to Citi. The firm upgraded the stock on Monday to buy from neutral and raised its price target to $60 from $36. Citi’s new forecast now implies more than 50% upside from Friday’s close. The company is best known for its RNA-based therapeutics. Analyst…

Health

FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease

Newsology2 years ago07 mins

[ad_1] A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration on Tuesday granted accelerated approval for Biogen‘s drug tofersen, which treats a rare and aggressive form of the disease known as ALS. Accelerated approval is an FDA…